Side-by-side comparison of AI visibility scores, market position, and capabilities
Colombia YC W23 dollar neobank with 200K+ users and $80M+ transactions; $4.2M Goodwater/Taisu/YC-backed USDC-powered peso-to-dollar banking competing with Nubank for LATAM consumer currency protection and dollar savings.
Littio is a Bogotá, Colombia-based dollar-denominated neobank — backed by Y Combinator (W23) with $4.2 million in total funding from Goodwater Capital, Taisu Ventures, and Y Combinator — providing Colombian consumers and Latin American users with dollar bank accounts, USDC-powered dollar savings, and international payment capabilities that protect savings from Colombian peso devaluation and enable seamless USD transactions. Having grown to 200,000+ Colombian users processing $80 million+ in transactions, Littio offers dollar accounts accessible via mobile app, allowing users to hold, send, and receive dollars at a time when Colombian peso volatility (the COP depreciated 20%+ against the USD between 2021 and 2024) makes dollar-denominated savings a critical wealth preservation strategy.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.